Quantinno Capital Management’s Corcept Therapeutics CORT Stock Holding History

Quantinno Capital Management’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.61M	Buy	41,537 +12,683	+44%	+$766K	﹤0.01%	1499
2026 Q1	$1.16M	Buy	28,854 +732	+3%	+$27.4K	﹤0.01%	2028
2025 Q4	$979K	Buy	28,122 +8,422	+43%	+$662K	﹤0.01%	1810
2025 Q3	$1.64M	Buy	19,700 +13,235	+205%	+$958K	﹤0.01%	1283
2025 Q2	$475K	Buy	6,465 +738	+13%	+$53.5K	﹤0.01%	1679
2025 Q1	$654K	Buy	+5,727	New	+$349K	﹤0.01%	1293
2021 Q1	–	Sell	-8,117	Closed	-$212K	–	263
2020 Q4	$212K	Sell	8,117 -10,337	-56%	-$218K	0.16%	313
2020 Q3	$321K	Sell	18,454 -13,863	-43%	-$221K	0.21%	250
2020 Q2	$544K	Sell	32,317 -22,155	-41%	-$311K	0.54%	10
2020 Q1	$648K	Buy	+54,472	New	+$674K	0.4%	58
2019 Q4	–	Sell	-23,744	Closed	-$336K	–	412
2019 Q3	$336K	Buy	+23,744	New	+$292K	0.23%	226
2019 Q2	–	Sell	-10,877	Closed	-$128K	–	440
2019 Q1	$128K	Buy	+10,877	New	+$135K	0.08%	361

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantinno Capital Management's CORT Position: Q2 2026 in Review

Quantinno Capital Management increased its Corcept Therapeutics (CORT) stake by 44% in Q2 2026, buying an estimated $766K and bringing the position to 41,537 shares worth $3.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1499.

Quantinno Capital Management first reported a position in CORT in Q1 2019 and has held it in 12 quarters since. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Quantinno Capital Management held 41,537 shares of Corcept Therapeutics worth $3.61M as of Q2 2026.
Quantinno Capital Management bought 12,683 Corcept Therapeutics shares in Q2 2026, an estimated $766K.
Corcept Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1499 holding.
Quantinno Capital Management first reported a position in Corcept Therapeutics in Q1 2019 and has held it in 12 quarters since.
422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.